To study the protective effects of maternal thyroxine (T4) and 3,5,3'-triiodothyronine (T3) in congenital hypothyroidism, we gave pregnant rats methimazole (MMI), an antithyroid drug that crosses the placenta, and infused them with three different doses of T4 or T3. The concentrations of both T4 and T3 were determined in maternal and fetal plasma and tissues (obtained near term) by specific RIAs. Several thyroid hormone-dependent biological end-points were also measured. MMI treatment resulted in marked fetal T4 and T3 deficiency. Infusion of T4 into the mothers increased both these pools in a dose-dependent fashion. There was a preferential increase of T3 in the fetal brain. Thus, with a T4 dose maintaining maternal euthyroidism, fetal brain T3 reached normal values, although fetal plasma T4 was 40% of normal and plasma TSH was high. The infusion of T3 into the mothers increased the total fetal extrathyroidal T3 pool in a dose-dependent fashion. The fetal T4 pools were not increased, however, and this deprived the fetal brain (and possibly the pituitary) of local generation of T3 from T4. As a consequence, fetal brain T3 deficiency was not mitigated even when dams were infused with a toxic dose of T3. The results show that (a) there is a preferential protection of the brain of the hypothyroid fetus from T3 deficiency; (b) maternal T4, but not T3, plays a crucial role in this protection, and (c) any condition which lowers maternal T4 (including treatment with T3) is potentially harmful for the brain of a hypothyroid fetus. Recent confirmation of transplacental passage of T4 in women at term suggests that present results are relevant for human fetuses with impairment of thyroid function. Finding signs of hypothyroidism at birth does not necessarily mean that the brain was unprotected in utero, provided maternal T4 is normal. It is crucial to realize that maintainance of maternal "euthyroidism" is not sufficient, as despite hypothyroxinemia, the mothers may be clinically euthyroid if their T3 levels are normal. (J. Clin. Invest. 1990. 86:889-899.)
Introduction
For years the mammalian placenta has been considered virtually impermeable to the thyroid hormones, L-thyroxine (T4) and 3,5,3'-triiodo-L-thyronine (T3) (1, 2). Thus, thyroid hormones would not be required for normal embryonic development before onset of fetal thyroid function (3, 4) . It has, however, been shown that rat and human embryonic tissues contain T4 and T3 before onset of fetal thyroid function, and that both are of maternal origin (5) (6) (7) (8) . The nuclear receptor for T3 is also found in human and rat brain early in pregnancy (7, 9) . The adverse effects of maternal hypothyroxinemia on the central nervous system (CNS) might be related to the thyroid hormone deficiency ofthe developing embryo (5, 8, (10) (11) (12) . In neurologic endemic cretinism the degree ofthe developmental disorders has been correlated to with that of maternal hypothyroxinemia (1 3).
Even when transfer of maternal thyroid hormones early in pregnancy is accepted (14) , it is believed that maternal transfer would not be necessary once the fetal thyroid is active; placental inner ring deiodinations would prevent the iodothyronines from reaching the fetus (2, 15). The fetal pituitary-thyroid axis functions with a great degree of autonomy: thyroid failure is accompanied by low T4 and elevated serum TSH levels. This, however, does not necessarily mean total independence from maternal thyroid status. Transfer of maternal thyroid hormones might still continue, and mitigate the effects of thyroid hormone deficiency until birth.
We have shown in rats that both T4 and T3 continue to be transferred from the mother to the fetus near term, when the fetal thyroid is impaired (16, 17) . The infusion of T4 to the mother (16) mitigated both T4 and T3 deficiency of the methyl-mercapto-imidazole-2-thiol (MMI)-treated fetus. The brain actually attained normal concentrations ofT3, at present considered as the intracellularly active iodothyronine (18) . In contrast, the infusion of T3 to the mother did not mitigate fetal cerebral T3 deficiency, although it increased the concentrations of T3 in other fetal tissues ( 17) .
These previous studies did not clarify several points of interest: (a) the range of maternal doses of T4 that would ensure normal T3 levels in the fetal brain; (b) whether, or not, a supraphysiological maternal supply of T4 would result in excessive concentrations of T3 in the fetal brain, and (c) whether or not, normalization of fetal brain T3 would eventually be attained with higher doses of maternal T3 than previously used. Such information may well be relevant to babies with congenital hypothyroidism. It has been recently shown by Vulsma et al. ( 19) that T4 is transferred from the mother to the hypothyroid baby up to birth: T4 levels in cord-blood from babies with total organification defect ranged from 2.7 to 5.4 ,g/dl, namely 25 to 50% of normal values, then decreasing with a half-life of disappearance of 3.6 d. Thus, in contrast with previous widespread opinion, maternal thyroid hormones might protect the human hypothyroid fetus, and especially its brain, at least up to birth.
The present paper reports results obtained in fetuses from rats treated with MMI, and infused with T4 or T3, at three different dose levels of each.
Methods
Experimental design. Female rats of a Wistar strain were used. They were mated with normal males, the day ofappearance ofa vaginal plug being considered as day 0 ofgestation (8) . They were divided into eight different groups (Table I) , comprising three dams each: seven of the eight groups were given 0.02% MMI as drinking water, starting on the morning ofthe 14th day ofgestation (MMI dams). The eighth group (C dams) did not receive MMI. At 15 d of gestation, all the dams were implanted with osmotic minipumps delivering at a constant rate either infusion solvent (dams of the C group and of one MMI group), T4 (three MMI + T4 groups) or T3 (three MMI + T3 groups). The doses of T4 and T3 are shown in Table I . The dams were killed at 21 d of gestation, and perfused as previously described in detail (8) , except that 6-N-propyl-2-thiouracil (PTU) was not added to the perfusion medium to avoid possible interferences with the measurements of outer-ring iodothyronine deiodinase activities. We used a total of 24 dams and their 223 fetuses.
Continuous infusion of T4 and T3. We used 2-ml Alzet osmotic minipumps (Alza Corp., Palo Alto, CA), implanted under the dorsal skin (16 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) ,000 cpm per pump), prepared as described further on, were added to the T4 or T3 solutions, respectively. The radioactivity of the pumps was determined before implanting them, and at the end of the experiment. This permitted us to control that the delivery rate in vivo had been the one specified by the manufacturers. Performance of the pumps was always satisfactory.
The T4 and T3 doses indicated in Table I Preparations ofsamples. Maternal plasma, liver, heart, and brain were excised. The fetuses were bled, separated from the placenta and immediately placed on ice. The thyroid, adhering to the trachea, was obtained under the dissecting microscope, and kept frozen. The liver, brain, heart, and lung were dissected out, weighed and frozen rapidly on dry ice. The interscapular brown adipose tissue (BAT) pads were also dissected out and used for a parallel study on fetal BAT 5'-iodothyronine deiodinase activity (20). The rest ofthe fetus, referred to here as the carcass (whole embryo minus the blood, trachea, thyroid, liver, lung, brain, heart, and BAT) was stored frozen. The fetal and maternal sides of each placenta were separated with blunt forceps, and stored frozen for a separate study (Calvo, R., et al., manuscript in preparation).
The thyroid glands were processed individually. Plasma from different fetuses were pooled, so that 300-400-Ml aliquots were obtained for extraction and determination of T4, T3, and TSH. Carcasses were processed individually, livers were pooled from two, brains from two to three, lungs and hearts from four to five fetuses to obtain -0.5 g of tissue per pool (except for 0. 1-0. 15 g per pool ofcardiac tissue). Tissues that were pooled were obtained from fetuses of the same litter. For most tissues there were two individual samples or pools/dam, and thus six pools for each of the eight experimental groups. All samples of a given tissue were processed in the same analytical run.
Determination of T4 and T3 concentrations. All samples, including maternal and fetal plasmas, were extracted and processed as described in detail (8, 16) . In brief, homogenization in methanol is followed by extraction in chloroform-methanol, back-extraction into an aqueous phase, and purification of this phase through Bio-Rad AG 1 X 2 resin columns (Bio-Rad Laboratories, Richmond, CA). The iodothyronines are eluted with 70% acetic acid, which is then evaporated to dryness. RIA buffer is added, and the samples are submitted to highly sensitive RIAs for the determination of T4 and T3, the limits of sensitivity being 2.5 pg T4 and 1.5 pg T3/tube. Each sample is processed in duplicate or triplicate at two or more dilutions. Results are then calculated using individual recovery data obtained after addition of [13' I] T4 and [125I] T3 during the initial homogenization process. The amounts of tracers added are such that the radioactivities carried over into the RIA tubes are too low to interfere with the determinations.
The total T4 and T3 contents of the fetal thyroids were determined in methanol extracts of proteolytic digests of whole glands (16) .
The synthesis of the high specific activity 125I-and 13'I-labeled tracers used for individual recovery calculations and of the labeled iodothyronines used as antigens for the T4 and T3 RIAs was carried out as described previously (8, 16) .
Other determinations. Plasma levels of thyrotrophic hormone (TSH) were measured using immunoreactants kindly supplied by the Rat Pituitary Agency ofthe National Institutes ofArthritis, Diabetes & Digestive and Kidney Diseases (NIADDK) of the National Institutes of Health (Bethesda, MD), as previously described (21) . Results are expressed in weight equivalents of the NIAMDDK-rTSH-RP-2 reference preparation.
The activity of intramitochondrial a-glycerophosphate dehydrogenase (a-GPD; EC 1.1.99.5) was measured in mitochondrial preparations from individual fetal livers as described by Lee and Lardy (22) for groups of unequal size. Square root or logarithmic transformations usually ensured homogeneity of variance when this was not found with the raw data. Significance of differences between groups was assessed using the protected LSD (least significance difference) test, and considered significant when P < 0.05. All these calculations were performed as described by Snedecor and Cochran (25). Whenever it is stated that a variable in a group is increased, or decreased, as compared to another group, it is implied that the difference between the mean values was statistically significant. Statistically significant differences of data from T4-or T3-infused MMI-treated dams and those of the C and MMI-treated animals are identified in Tables that appear in the Appendix.
Results
Infusion doses maintaining euthyroidism in MMI-treated dams Maternal plasma and tissue T4 and T3 concentrations are shown in the left-hand panels of Figs. 1 and 2, and biological end-points of thyroid hormone action, such as circulating TSH, cerebral cortex 5' D-II and liver a-GPD activities in the left-hand panels of Fig. 3 . In all the figures results corresponding to C or MMI-treated dams are shown as shaded areas, which enclose the mean value±SEM. The results corresponding to T4 (or T3) infused MMI-treated dams are represented as dose-response curves.
As may be seen, MMI treatment for 7 d decreased the levels of both T4 and T3 in plasma and all maternal tissues studied.
CHANGES IN THE CONCENTRATIONS OF T4 (FIG. 1)
In dams infused with T4. Dose-response relationships were found between the T4 dose and T4 levels in maternal plasma and tissues. The changes in tissues, however, were not necessarily the same as in plasma. Concentrations of T4 in the heart and liver of MMI-treated dams infused with the 1 .8-,ag T4 dose (for the sake of simplification, doses given henceforth refer to the daily dose per 100 g BW per d, at 15 d of gestation, even if this is not explicitly stated each time) were normal (that is, comparable to those of C dams), whereas in brain they were higher, and in plasma lower. Plasma T4 was comparable to C values in dams infused with the 2.4-tug T4 dose, whereas T4 levels were higher than normal in all the tissues studied. Although the concentrations of T4 exceeded C values in all maternal samples with the 3.6-Mg T4 dose, they did not increase above those of nonpregnant females of similar age (26), except for the brain.
In dams infused with T3. Doses ranging from 0.5 to 4.5 ,ug T3 either had no effect on T4 levels in plasma and tissues ofthe MMI-treated dams, or actually decreased them, especially when the highest T3 dose was used.
CHANGES IN THE CONCENTRATIONS OF T3 (FIG. 2)
In dams infused with T3. The dose-response relationships between the T3 dose and T3 levels were not the same for tissues and plasma. T3 levels in the brain of dams infused with 0.5 Ag T3 did not attain C values, although T3 levels were normal in plasma and heart, and elevated in the liver. Infusion of the 1.5-,ug T3 dose resulted in normal T3 in plasma and brain, but liver and heart levels were higher than in C dams. The highest T3 dose, namely 4.5 gg T3, increased T3 levels in all maternal samples both above C values and above those of normal nonpregnant female rats (26). The changes in cerebral T3 were striking: with the lowest T4 dose, T3 concentrations in the brain were almost 50% of control values, despite the fact that this dose did not increase T3 in fetal plasma and other fetal tissues above MMI levels. Brain T3 levels were the same as those of normal fetuses with the 2.4-,ug T4 dose, and did not exceed them in fetuses from dams receiving the highest dose. Thus, brain T3 was normal in fetuses in which both plasma T3 and T4 were still low: T4 was -40% of C values, and T3 was in the MMI range.
FETAL BRAIN T4 AND T3 VERSUS TOTAL EXTRATHYROIDAL POOLS
The total extrathyroidal T4 and T3 pools (Fig. 5, left) were calculated by adding the amounts of each hormone contained in plasma, fetal organs and carcass (The mean concentration values and the mean organ weights were used to calculate the T4 [or T3] contents in each tissue. The mean total blood volume was calculated as 16.8% of body weight, based on data obtained in rat fetuses near term [27] . Data for BAT were from Comparison of both panels stresses the finding that brain T3 was normal in fetuses from MMI-treated dams infused with doses of T4 which were insufficient to avoid T4 and T3 deficiency of the fetus as a whole. T3 deficiency of the fetus could be prevented by the infusion of a supraphysiological dose of T3, but this had no mitigating effect on fetal brain T3 deficiency.
Changes in the concentrations of T4 (Figs. I and 4 Fetal plasma TSH and T4 were inversely related, y = 8.99 . 10-01'96X (where y = ng TSH/ml, and x = ng T4/ml), r = 0.98. In contrast with findings in the mothers, fetal plasma TSH and T3 levels were not inversely related. Plasma TSH in fetuses from T3-infused dams was as high as in fetuses from dams on MMI alone, even with the highest T3 dose, which increased fetal plasma T3 above C levels.
Changes in a-GPD activities in the fetal liver were not as clearly thyroid hormone-dependent as in the maternal liver, although the infusion of T3 into the MMI-treated dams appeared to have a dose-related effect.
Discussion
Maintainance of maternal euthyroidism: T4 versus T3. Infusion ofeither T4 or T3 alone does not normalize both T4 and T3 in plasma and all tissues. The 2.4-,ug T4 dose increased T3 in maternal plasma and tissues to normal levels and also reversed several biological end-points of thyroid hormone action to normal values, although T4 concentrations were higher than in normal pregnant dams. Gray and Galton (28) found that daily subcutaneous injections of 2 ,gg T4/100 g BW maintained thyroidectomized pregnant rats euthyroid. They increased the dose with increasing BW, so that near term it was actually very similar to the present 2.4 ,g T4 infusion dose, which was 1.7 Ag T4/100 g BW per d by 21 d of gestation. The present MMItreated dams on this dose were considered equivalent to euthyroid C dams. So were the MMI-treated dams receiving the 0.5-to 1.5-jig T3 doses, although it must be kept in mind that they differed from normal euthyroid dams in an important respect, namely, that they have very low T4 pools and are thus deprived of substrate for regulatory mechanisms involving local generation of T3 from T4 (29) .
Transfer of T4 and T3 from the mother to the conceptus. Comparison of changes in T4 and T3 levels in maternal versus fetal samples (fetal brain T3 excluded) confirms that both iodothyronines cross the rat placenta near term (16, 17) . The fetal T4 and T3 levels are related to the dose of the parent iodothyronine infused into the mothers, but the slopes of the dose-response curves are lower for fetal, as compared to maternal, plasma and tissues. Transfer is, therefore, not free, but limited. It is quite likely that the placenta plays an important role in this, as previously proposed by others (2) and reported elsewhere (Calvo, R., et al., in preparation).
Present results contradict the notion that the placenta avoids transfer of any T4 or T3 from the mother to the fetus (2, 15). We have indeed recently found that at 21 d of gestation the net maternal contribution represents 17.5±0.9% of the total fetal extrathyroidal T4 pool (30) (Normal dams were infused with high specific activity [1251] T4, plus KI to block 125I recycling, from 11 to 21 d of gestation, at which time isotopic equilibrium was reached and the specific activity of the [12511] T4 was determined in maternal and fetal tissues. Comparison of these values allows calculation of the net maternal contribution to fetal extrathyroidal T4 [30] .) Moreover, preliminary data indicate that transfer of T4 is not increased, in absolute amounts, by MMI-induced fetal thyroid failure (30) .
Infusion ofT4 versus T3 into the mother; differential effects onfetal thyroid hormone economy. Present results, as summarized in Fig. 5 , show that infusion of T4 into the mothers mitigates both the T4 and T3 deficiency ofthe fetus as a whole, and is especially beneficial for the fetal brain. In contrast, maintainance of maternal euthyroidism with T3 deprives the fetus of regulatory mechanisms that require T4 for the intracellular supply of T3 (29), as already indicated for their mothers.
The consequences of an inadequate supply of T4 are more dramatic for the fetal than for the adult brain. Administration of a dose of T3 which was clearly supraphysiological for the mother did not increase fetal brain T3 above MMI levels, despite restoration of the total extrathyroidal T3 pool to normal values.
Thus, the fetal brain appears to depend on local conversion of T4 to T3 for its T3 supply to a much greater extent than in adult rats, as previously discussed (17, 23) . This had been documented for neonatal rats 2 wk after birth by Silva and Matthews (31) . The fetal brain is exclusively dependent on local generation of T3 from T4, although in the mothers a certain proportion of intracerebral T3 is derived from plasma T3. For non-pregnant adult rats almost half the T3 bound to nuclei would be derived from plasma T3 according to Crantz et al. (32) , about 33% for cortex and 50% for cerebellum according to van Doorn et al. (33) . Dickson et al. (34) have shown that the choroid plexus of adult rats accumulates T4, but not T3, in vitro. This structure appears to be important in the transfer of the iodothyronines into the brain. Present results suggest that the difference between the uptake of T4 and T3 might be even greater during fetal development, and/or that alternative pathways for the entry of the iodothyronines into the brain, which would account for uptake of T3 from plasma in adult rats, have not yet developed.
T4 and T3 concentrations were not measured in the fetal pituitaries because of technical difficulties. The dose-response curves obtained for fetal plasma TSH, however, suggest that the changes in T4 and T3 levels in the pituitary would resemble those observed in the fetal brain. It is possible that the contribution of plasma T3 to intrapituitary T3 content is lower during fetal life than it is in adults and depends, as is the case for the brain, mostly on local conversion of T4 to T3 for its intracellular supply of T3. The rat pituitary is apparently not sensitive to T3 until 5 d postnatally (35) , although Knobil and Josimovich (36) found some limited effects of very high doses of T3 on the fetal pituitary, as measured by an antigoiter assay.
The lack of participation of plasma-derived T3 in the cerebral (and possibly, hypophyseal) supply ofT3 during fetal life is not, however, a general characteristic of tissues with high 5' D-II activities. T3 concentrations in fetal BAT (20) not only increased with the infusion of 2.4 and 3.6 ,ug T4 into the dams, but also when the 4.5-,ug T3 dose was infused.
Maternal thyroxinemia and the preferential protection of the fetal brain from T3 deficiency. We wish to stress that a normal maternal thyroxinemia (dams on the 2.4-,gg T4 dose) results in the preferential protection of the brain in fetuses which would be detected as congenitally hypothyroid on the basis of their plasma T4 (only 40% of normal), and their elevated plasma TSH. "Clinical" signs of congenital hypothyroidism might be detected in such fetuses near term (or in the newborns), but this would not necessarily mean that the brain had also been T3 deficient in utero, provided maternal thyroxinemia was normal. A relatively minor degree of maternal hypothyroxinemia (dams on the 1.8-,ug T4 dose) would no longer be adequate for total protection: T3 was only 50% of normal. In contrast, a slightly increased maternal thyroxin-emia (dams on the 3.6-Atg T4 dose), did not result in excessive fetal brain T3. Extrapolation of the dose-response curves for fetal brain T4 concentrations (Fig. 1) and 5' D-II activity (Fig.  3) suggests that normal brain T4 levels and 5' D-II activities might not be reached until the dose infused into the dams increased to 5-6 tug T4/100 g BW/d considering that brain 5' D-II is regulated by the concentration of T4, not by T3 levels in the physiological range (37) . It seems unlikely that fetal brain T3 levels would become excessive until the maternal supply of T4 exceeded these doses, which are approximately double the dose ensuring maternal euthyroidism. This point, however, remains to be investigated.
Mechanisms involved in the preferential protection of the fetal brainfrom T3 deficiency. The mechanisms which lead to a preferential protection during this important period of neurogenesis are not yet well defined. The ability of fetal brain 5' o-II to increase four-to fivefold in response to hypothyroidism (22) obviously plays an important role. It is also possible that a decrease in inner-ring iodothyronine deiodinase activity contributes to the increase in cerebral T3: activity ofthis enzyme is high in fetal brain and, contrary to 5' D-II, decreases with hypothyroidism (38) . Cerebral uptake of T4 might also be increased, as suggested indirectly by the concentrations of the iodothyronines in plasma and tissues. Although plasma T4 and T3 in C fetuses are only 20.7% and 12.5%, respectively, of the maternal levels, and fetal liver T4 and T3 are 19.8% and 13.2% of those in maternal liver, fetal brain T4 and T3 are 140% and 77% of maternal cerebral levels. The brain to plasma T4 ratio was almost seven times higher in the brain of C fetuses (0.364) than in the maternal brain (0.054), whereas liver to plasma T4 ratios were very similar for C dams (1.16) and their fetuses ( 1.1 1). Previous studies carried out in 2-wk-old rat pups (29) showed that the neonatal brain responds to hypothyroidism with an increase in cerebral conversion of T4 to T3, in T3 residence time, and in T3 uptake.
Conclusions regarding the main aims of this study. The findings presented here show that a normal maternal supply of T4 is essential for the preferential protection of the fetal brain from T3 deficiency. A 50% increase in the maternal supply of T4 above the "physiological" dose does not result in excessive brain T3. The fetal brain is entirely dependent on T4, and not on plasma T3, for its intracellular supply of T3 (23 (39) (40) (41) , the more recent consensus was that it would be negligible in quantitative terms (1, 2, 42, 43). This notion was partly due to the lack ofeffect ofincreasing doses ofT3 on cord-blood TSH (44, 45 Maternal transfer of thyroid hormones is not sufficient to compensate completely for the lack of fetal thyroid function: babies with congenital thyroid failure are often born with signs of hypothyroidism, such as the absence of ossification centers that are present at birth in normal babies (4, (46) (47) (48) . Moreover, most of their central nervous system (CNS) damage may be prevented by prompt postnatal treatment (49) (50) (51) . From these observations it has been concluded (4, 15) that transfer is physiologically irrelevant and the human brain does not require thyroid hormone for normal development until after birth. The latter conclusion, however, does not take into consideration that not all of the CNS damage is prevented by immediate and proper postnatal treatment (49-52). The hypothesis also contrasts with evidence in species, such as the rat, where thyroidectomy at a stage of brain development grossly equivalent to that of a human fetus at mid-gestation results in profound effects on many phases of brain maturation that occur in utero in man (for reviews, and references of previous reviews, see [52] [53] [54] (13) . The fetus is deprived of T4 throughout pregnancy, initially because of maternal hypothyroxinemia, and later in gestation because maternal hypothyroxinemia continues and the fetal thyroid cannot produce enough T4 due to the scarce supply of iodine ( 12, 13) . Maternal levels of total and free T3 are normal and may prevent the manifestation of clinical hypothyroidism in such women and in the neurological cretins born from them (56) . But Fig. 1 . It identifies the statistically significant differences in the concentration of T4 in plasma and tissues of MMI-treated dams (or of their fetuses) infused with T4 or T3, as compared both to the C and the MMI-treated groups. The transformation of the data required for homogeneity of variances is given in brackets: (-) indicates that the variances were homogeneous using the raw data. All T4 values for the MMI-treated dams or their fetuses were significantly decreased versus C. NS, Not significantly different. * P < 0.05. §P < 0.01. tP < 0.001. T3  T3  T3  T3  T3  T3  T3  T3  (- 
